D. Stevens

发表

Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure.

D. Stevens, A. Bryant, S. Hackett, 1996, The Journal of infectious diseases.

Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O.

D. Stevens, S. Hackett, Sean P. Hackett, 1992, The Journal of infectious diseases.

Severe sepsis and septic shock: review of the literature and emergency department management guidelines.

David T. Huang, S. Trzeciak, T. Osborn, 2006, Annals of emergency medicine.

Antibiotic susceptibilities of human isolates of Pasteurella multocida

D. Stevens, J. Higbee, T. R. Oberhofer, 1979, Antimicrobial Agents and Chemotherapy.

Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

Patchen Dellinger, Jan V Hirschmann, A. Bisno, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Streptococcal infections of skin and soft tissues.

D L Stevens, A. Bisno, D. Stevens, 1996, The New England journal of medicine.

Epidemiologic investigation of methicillin resistant Staphylococcus aureus in a burn unit.

D. Stevens, E. Everett, T. McNitt, 1978, Military medicine.

Analysis of circulating phagocyte activity measured by whole blood luminescence: correlations with clinical status.

R. Allen, D. Stevens, A. Bryant, 1994, The Journal of infectious diseases.

Invasive group A streptococcus infections.

D. Stevens, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens.

C. Lee, D. Stevens, A. Bryant, 2000, The Journal of infectious diseases.

Streptococcal infections: clinical aspects, microbiology, and molecular pathogenesis.

E. Kaplan, D. Stevens, 2000 .

The flesh-eating bacterium: what's next?

D. Stevens, 1999, The Journal of infectious diseases.

A novel murine model of Clostridium sordellii myonecrosis: Insights into the pathogenesis of disease.

D. Stevens, A. Bryant, M. J. Aldape, 2016, Anaerobe.

Streptococcal toxic shock syndrome associated with necrotizing fasciitis.

D. Stevens, 2000, Annual review of medicine.

Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cells

B. McClane, D. Stevens, B. Fleischer, 1997, Infection and immunity.

Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus.

D. Stevens, A. Bryant, Yongsheng Ma, 2007, The Journal of infectious diseases.

Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit.

R. Wunderink, M. Kollef, R. Balk, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fatal S. aureus Hemorrhagic Pneumonia: Genetic Analysis of a Unique Clinical Isolate Producing both PVL and TSST-1

A. Kearns, D. Stevens, A. Bryant, 2011, PloS one.

Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome.

D. Stevens, A. Bryant, D. Salmi, 2000, The Journal of infectious diseases.

Streptococcal Infections

D. Stevens, B. Gray, 2009, Bacterial Infections of Humans.

Streptococcal Toxic Shock Syndrome (STSS)

E. Kaplan, M. Kotb, P. Schlievert, 1997 .

Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation.

E. Kaplan, M. Kotb, P. Schlievert, 1997, Advances in experimental medicine and biology.

Mycobacterium fortuitum Meningitis Associated with an Epidural Catheter: Case Report and a Review of the Literature

D. Stevens, K. Madaras-Kelly, T. Demasters, 1999, Pharmacotherapy.

Role of θ Toxin, a Sulfhydryl-Activated Cytolysin, in the Pathogenesis of Clostridial Gas Gangrene

D. Stevens, A. Bryant, 1993 .

Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity.

D. Stevens, M. Norgren, B. Eriksson, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?

D. Stevens, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers.

T. File, D. Stevens, G. Petropoulos, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

P. Schlievert, D. Stevens, E. Kaplan, 1989, The New England journal of medicine.

Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome

E. Kaplan, P. Schlievert, D. Stevens, 1991, Journal of clinical microbiology.

SEVERE GROUP A STREPTOCOCCAL INFECTIONS ASSOCIATED WITH A TOXIC SHOCK-LIFE SYNDROME AND SCARLET FEVER TOXIN

P. Schlievert, D. Stevens, E. Kaplan, 1990 .

Invasive streptococcal infections

D. Stevens, 2001, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The toxins of group A streptococcus, the flesh eating bacteria.

D. Stevens, 1997, Immunological investigations.

The toxic shock syndromes.

D. Stevens, 1996, Infectious disease clinics of North America.

Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections.

D. Stevens, M. Chaussee, J. Ferretti, 1996, The Journal of infectious diseases.

Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.

Dwight R. Johnson, E. Kaplan, D. Stevens, 1992, The Journal of infectious diseases.

Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection.

R. Lieber, D. Stevens, A. Bryant, 2008, The Journal of infectious diseases.

Identification and Characterization of Bicistronic speB and prsA Gene Expression in the Group A Streptococcus

D. Stevens, A. Bryant, Yongsheng Ma, 2006, Journal of bacteriology.

Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes.

D. Stevens, A. Bryant, P. Guth, 2005, The Journal of infectious diseases.

Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns.

P. Jansen, F. Taylor, D. Stevens, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes.

D. Stevens, A. Bryant, C. R. Bayer, 2006, The Journal of infectious diseases.

Comparison of adherence to and penetration of a human laryngeal epithelial cell line by group A streptococci of various M protein types.

D. Stevens, J. Dale, M. Hagman, 1999, FEMS immunology and medical microbiology.

Invasive group A streptococcal disease.

D. Stevens, 1996, Infectious agents and disease.

Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review.

E. Kaplan, M. Martinelli, D. Stevens, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

D. Stevens, A. Bryant, S. Hamilton, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Emerging Treatments for Resistant Bacterial Infections and Pathogen-Focused Therapy

J. Bartlett, L. Rice, G. Eliopoulos, 2008 .

Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit.

R. Wunderink, M. Kollef, R. Balk, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections

D. Stevens, A. Bryant, M. J. Aldape, 2015, Current opinion in infectious diseases.

Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis.

D. Stevens, A. Bryant, S. Hamilton, 2014, The Journal of infectious diseases.

Toll receptors, CD14, MD-2 and NOD2: their role in health and acute and chronic infectious diseases.

D. Stevens, 2002, Current opinion in infectious diseases.

Effects of delayed NSAID administration after experimental eccentric contraction injury – A cellular and proteomics study

Thomas L. Fillmore, B. Webb-Robertson, T. Clauss, 2017, PloS one.

The Pathogenesis of Gas Gangrene

D. Stevens, A. Bryant, 1997 .

Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells

D. Stevens, A. Bryant, A E Bryant, 1996, Infection and immunity.

Necrotizing Soft-Tissue Infections.

D. Stevens, A. Bryant, 2018, The New England journal of medicine.

Group a Streptococcal and Staphylococcal Infections

D. Stevens, A. Bryant, 2011 .

Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections.

J. P. Davis, E. Kaplan, B. Schwartz, 1993, JAMA.

Expression of activational markers on circulating leukocytes from baboons with group A streptococcal (GAS) bacteremia.

D. Stevens, A. Bryant, 1997, Advances in experimental medicine and biology.

Cardiac Myocyte Dysfunction Induced by Streptolysin O Is Membrane Pore and Calcium Dependent

D. Stevens, A. Bryant, R. Tweten, 2015, Shock.

Group A streptococcal sepsis

D. Stevens, 2003, Current infectious disease reports.

Invasive group A streptococcal infection: New concepts in antibiotic treatment.

D. Stevens, A. Bryant, S. Yan, 1994, International journal of antimicrobial agents.

Selective Depletion Of Vβ-Bearing T Cells In Patients With Severe Invasive Group A Streptococcal Infections And Streptococcal Toxic Shock Syndrome

B. Schwartz, M. Kotb, D. Low, 1995 .

The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

V. Winn, D. Stevens, R. Bergstrom, 1988, The Journal of infectious diseases.

Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.

E. Kaplan, D. Stevens, W. M. McShan, 1999, The Journal of infectious diseases.

Streptococcus pyogenes NAD+-Glycohydrolase Reduces Skeletal Muscle βNAD+ Levels Independently of Streptolysin O

D. Stevens, A. Bryant, Sarah E. Hobdey, 2022, Microorganisms.

Current Approaches to Group A Streptococcal Vaccine Development -- Streptococcus pyogenes: Basic Biology to Clinical Manifestations

D. Stevens, Ferretti Jj, Fischetti Va, 2016 .

Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention.

K. O'Brien, A. Bisno, A. Schuchat, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Enrichment of Antigen-Specific Class-Switched B Cells from Individuals Naturally Immunized by Infection with Group A Streptococcus

D. Stevens, Sarah E. Hobdey, E. McIndoo, 2019, Msphere.

Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]

V. Fischetti, D. Stevens, J. Ferretti, 2016 .

Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect.

D. Stevens, A. Bryant, S. Yan, 1993, The Journal of infectious diseases.

Construction and virulence testing of a collagenase mutant of Clostridium perfringens.

M. Awad, J. Rood, D. Stevens, 2000, Microbial pathogenesis.

Serious group a streptococcal infections.

D. Stevens, Christopher J. Wong, 2013, The Medical clinics of North America.

Folliculitis, Furuncles, and Carbuncles

D. Stevens, 2012 .

In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.

K. Carroll, D. Stevens, A. Bryant, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genetics of MRSA: The United States and Worldwide

D. Stevens, 2007 .

Haemophilus influenzae pneumonia in adults.

D. Stevens, E. Everett, T. McNitt, 1972, JAMA.

Randomized Comparison of Linezolid (PNU-100766) versus Oxacillin-Dicloxacillin for Treatment of Complicated Skin and Soft Tissue Infections

D. Stevens, J. Bruss, B. Hafkin, 2000, Antimicrobial Agents and Chemotherapy.

Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1

D. Stevens, S. Hackett, Y. Chi, 1994, Molecular microbiology.

Necrotizing Clostridial Soft Tissue Infections

D. Stevens, 1997 .

11 – Necrotizing Fasciitis, Gas Gangrene, Myositis and Myonecrosis

D. Stevens, A. Bryant, M. J. Aldape, 2017 .

Clostridium perfringens and Other Life-Threatening Clostridial Soft Tissue Infections

D. Stevens, A. Bryant, M. J. Aldape, 2015 .

Staphylococcus aureus α-hemolysin promotes platelet-neutrophil aggregate formation.

D. Stevens, A. Bryant, Devin D. Bolz, 2013, The Journal of infectious diseases.

‘Flesh-eating’ necrotizing infections: must we amputate?

D. Stevens, A. Bryant, 2012, Expert review of anti-infective therapy.

Life-threatening clostridial infections.

D. Stevens, A. Bryant, M. J. Aldape, 2012, Anaerobe.

Clostridial Myonecrosis: New Insights in Pathogenesis and Management

D. Stevens, A. Bryant, 2010, Current infectious disease reports.

Clostridium perfringens phospholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis.

D. Stevens, A. Bryant, R. Titball, 2006, Journal of medical microbiology.

CHAPTER 55 – Clostridial toxins in the pathogenesis of gas gangrene

D. Stevens, A. Bryant, 2006 .

Immunization with the C-Domain of alpha -Toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens.

D. Stevens, A. Bryant, R. Titball, 2004, The Journal of infectious diseases.

The role of clostridial toxins in the pathogenesis of gas gangrene.

D. Stevens, A. Bryant, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene.

C. Lee, D. Stevens, A. Bryant, 2000, The Journal of infectious diseases.

Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens.

R. Olson, D. Stevens, D. Merrick, 1988, The Journal of infectious diseases.

Effect of antibiotics on toxin production and viability of Clostridium perfringens

D. Stevens, J. Mitten, K. A. Maier, 1987, Antimicrobial Agents and Chemotherapy.

Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens

D. Stevens, B. Laine, J. Mitten, 1987, Antimicrobial Agents and Chemotherapy.

Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein.

G. Zimmerman, D. Stevens, A. Bryant, 1993, FEMS immunology and medical microbiology.

Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.

D. Stevens, B. Laine, J. Mitten, 1987, The Journal of infectious diseases.

Identiﬁcation and Characterization of Bicistronic speB and prsA Gene Expression in the Group A Streptococcus (cid:1)

D. Stevens, A. Bryant, Yongsheng Ma, 2006 .

Group A streptococcus--from basic science to clinical disease.

D. Stevens, 1996, The Western journal of medicine.

An outbreak of group A Streptococcal infection among health care workers.

Dwight R. Johnson, E. Kaplan, D. Stevens, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Necrotizing Soft-Tissue Infections.

D. Stevens, A. Bryant, 2017, The New England journal of medicine.

Streptococcus groups A, B, C, D, and G

D. Stevens, K. Madaras-Kelly, J. A. Mebane, 2021, Schlossberg's Clinical Infectious Disease.

Necrotizing Soft Tissue Infections.

E. Goldstein, D. Stevens, A. Bryant, 2020, Infectious disease clinics of North America.

Dilemmas in the treatment of invasive Streptococcus pyogenes infections.

D. Stevens, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Superantigens: their role in infectious diseases.

D. Stevens, 1997, Immunological investigations.

Invasive Group A Streptococcal Infections

D. Stevens, 2002 .

Direct effects of purified staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria.

R. Olson, D. Stevens, M. Melish, 1989, Reviews of Infectious Diseases.

Spontaneous C. septicum gas gangrene: A literature review.

D. Stevens, A. Bryant, M. J. Aldape, 2017, Anaerobe.

Spontaneous, nontraumatic gangrene due to Clostridium septicum.

D. Musher, D. Stevens, F. Gyorkey, 1990, Reviews of infectious diseases.

Type-specific opsonophagocytosis of group A Streptococcus by use of a rapid chemiluminescence assay.

D. Stevens, A. Bryant, A. Villaseñor-S, 1999, The Journal of infectious diseases.

Impetigo, Erysipelas and Cellulitis

D. Stevens, A. Bryant, 2016 .

Streptococcal pyrogenic exotoxin A and streptolysin O enhance polymorphonuclear leukocyte binding to gelatin matrixes.

D. Stevens, A. Bryant, M. Kehoe, 1992, The Journal of infectious diseases.

In Vitro Antimicrobial Effects of Various Combinations of Penicillin and Clindamycin against Four Strains of Streptococcus pyogenes

D. Stevens, K. Madaras-Kelly, D. M. Richards, 1998, Antimicrobial Agents and Chemotherapy.

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.

J. Hunt, H. Lampiris, D. Stevens, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sub‐lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro

D. Stevens, A. Bryant, M. J. Aldape, 2018, Journal of medical microbiology.

Origin of Cyanide in Cultures of a Psychrophilic Basidiomycete

G. Strobel, D. Stevens, 1968, Journal of Bacteriology.

CURRENT CONCEPTS IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS

D. Stevens, 1998 .

Invasive group A streptococcal infections: the past, present and future

D. Stevens, 1994, The Pediatric infectious disease journal.

Virulence studies on chromosomal α‐toxin and Θ‐toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α‐toxin in Clostridium perfringens‐mediated gas gangrene

J. Rood, D. Stevens, A. Bryant, 1995, Molecular microbiology.

Activation of platelet gpIIbIIIa by phospholipase C from Clostridium perfringens involves store-operated calcium entry.

D. Stevens, A. Bryant, C. R. Bayer, 2003, The Journal of infectious diseases.

The leukemoid reaction in Clostridium sordellii infection: neuraminidase induction of promyelocytic cell proliferation.

D. Stevens, A. Bryant, Yongsheng Ma, 2007, The Journal of infectious diseases.

UvA-DARE ( Digital Academic Repository ) Staging of the baboon response to group A streptococci administered intramuscul ; ary : a descriptive study of the clinical symptoms and clinical chemical response patterns

P. Jansen, D. Stevens, A. Bryant, 1999 .

Antibiotic effects on bacterial viability, toxin production, and host response.

D. Stevens, A. Bryant, S. Hackett, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock.

D. Stevens, A. Bryant, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of Clostridium perfringens recombinant and crude phospholipase C and theta-toxin on rabbit hemodynamic parameters.

R. Olson, D. Asmuth, D. Stevens, 1995, The Journal of infectious diseases.

Life-Threatening Skin and Soft-Tissue Infections

D. Stevens, A. Bryant, 2012 .

Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile.

D. Stevens, A. Bryant, M. J. Aldape, 2013, Journal of medical microbiology.

Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin‐sensitive and methicillin‐resistant Staphylococcus aureus

D. Stevens, E. Katahira, Stephen M. Davidson, 2019, Journal of medical microbiology.

The circulating phagocyte reflects the in vivo state of immune defense

R. Allen, D. Stevens, 1992 .

Cytokines: an updated compendium

D. Stevens, 1995 .

M Type 1 and 3 Group A Streptococci Stimulate Tissue Factor-Mediated Procoagulant Activity in Human Monocytes and Endothelial Cells

D. Stevens, A. Bryant, S. M. Hayes-Schroer, 2003, Infection and Immunity.

Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis.

D. Stevens, S. Hackett, Dennis L. Stevens, 1993, The Journal of infectious diseases.

A review of linezolid: the first oxazolidinone antibiotic

D. Stevens, K. Madaras-Kelly, B. Dotter, 2004, Expert review of anti-infective therapy.

Advances in the medical management of skin and soft tissue infections

D. Stevens, Jefferson G. Bohan, Sarah L McClain, 2016, British Medical Journal.

Efficacy of Iclaprim in Complicated Skin and Skin Structure Infections: Preliminary Results of ASSIST-1

D. Stevens, 2007 .

The role of vancomycin in the treatment paradigm.

D. Stevens, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

E. P. Dellinger, A. Bisno, J. Montoya, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

Jan V Hirschmann, E. P. Dellinger, A. Bisno, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Persistent acylation of high-molecular-weight penicillin-binding proteins by penicillin induces the postantibiotic effect in Streptococcus pyogenes.

D. Stevens, G. Bohach, S. Yan, 1994, The Journal of infectious diseases.

Investigating the immunomodulatory activities of omadacycline

D. Stevens, A. Bryant, 2022, The Journal of antimicrobial chemotherapy.

Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks.

D. Stevens, R. Bergstrom, A. Gibbons, 1989, Diagnostic microbiology and infectious disease.

Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.

D. Stevens, 1995, Emerging infectious diseases.

199 – Streptococcus pyogenes

D. Stevens, A. Bryant, Dennis L. Stevens, 2015 .

Erysipelas and Cellulitis

D. Stevens, 2012 .

Botulism, gas gangrene, and clostridial gastrointestinal infections

D. Stevens, A. Bryant, M. J. Aldape, 2010, Oxford Textbook of Medicine.

Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens.

D. Stevens, A. Bryant, J. Mader, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

10 – Cellulitis, Pyoderma, Abscesses, and Other Skin and Subcutaneous Infections

D. Stevens, 2017 .

Chapter 9 – Cellulitis, pyoderma, abscesses and other skin and subcutaneous infections

D. Stevens, 2010 .

Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment.

D. Stevens, A. Bryant, M. J. Aldape, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound

D. Stevens, T. Albert, 2010, Infection.

Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections

K. Itani, J. Weigelt, D. Stevens, 2005, Antimicrobial Agents and Chemotherapy.

Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens

M. Awad, J. Rood, D. Stevens, 1994, Molecular microbiology.

Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.

D. Stevens, A. Bryant, M. J. Aldape, 2015, The Journal of antimicrobial chemotherapy.

Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.

D. Stevens, M. Drehobl, F. Pien, 1993, Diagnostic microbiology and infectious disease.

Haemophilus influenzae pneumonia in adults.

D. Stevens, E. Everett, A. E. Rahm, 1977, British medical journal.

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

R. F. Johnston, Robert W. Taylor, Steven C. Johnson, 1994 .

Clinical courses of seven survivors of Clostridium septicum infection and their immunologic responses to alpha toxin.

D. Anderson, D. Stevens, R. Tweten, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative efficacy of antibiotics in treating experimental Clostridium septicum infection.

D. Stevens, A. Bryant, M. J. Aldape, 2018, International journal of antimicrobial agents.

Evaluation of an Intervention Designed to Decrease the Rate of Nosocomial Methicillin-Resistant Staphylococcus aureus Infection by Encouraging Decreased Fluoroquinolone Use

D. Stevens, K. Madaras-Kelly, Richard E. Remington, 2006, Infection Control & Hospital Epidemiology.

Clostridial Gas Gangrene: Evidence That α and θ Toxins Differentially Modulate the Immune Response and Induce Acute Tissue Necrosis

M. Awad, J. Rood, D. Stevens, 1997 .

Innate immune recognition of, and response to, Clostridium sordellii.

D. Stevens, A. Bryant, A. Hajjar, 2010, Anaerobe.

vfr, a Novel Locus Affecting Cysteine Protease Production in Streptococcus pyogenes

D. Stevens, A. Bryant, Yongsheng Ma, 2009, Journal of bacteriology.

Pathogenesis and the immune response

D. Stevens, 1997 .

Emerging erythromycin and clindamycin resistance in group A streptococcus: Efficacy of linezolid and tedizolid in experimental necrotizing infection.

D. Stevens, A. Bryant, M. J. Aldape, 2020, Journal of Global Antimicrobial Resistance.

Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.

J. Śanchez-Corona, D. Stevens, A. Bryant, 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Editorial: Pathogenesis and host response in the era of modern diagnostics: let's continue the basics.

D. Stevens, A. Bryant, 2019, Current opinion in infectious diseases.

The pathogenesis of clostridial myonecrosis.

D. Stevens, Dennis L. Stevens, 2000, International journal of medical microbiology : IJMM.

Effects of α and θ Toxins from Clostridium perfringens on Human Polymorphonuclear Leukocytes

D. Stevens, J. Mitten, C. Henry, 1987 .

Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes.

D. Stevens, J. Mitten, C. Henry, 1987, The Journal of infectious diseases.

Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficile in vitro

D. Stevens, A. Bryant, M. J. Aldape, 2017, Journal of medical microbiology.

Differential white blood cell count: underutilized or overrated.

D. Stevens, D. Dale, H. Rosen, 2000, Current opinion in infectious diseases.

β‐Adrenoceptor‐mediated modulation of calcium ionophore activated polymorphonuclear leucocytes

D. Stevens, R. Vestal, C. P. Nielson, 1986, British journal of pharmacology.

Netter's Infectious Disease

F. Netter, D. Stevens, E. Jong, 2014 .

Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans.

R. Robison, D. Teplow, J. Jensen, 2002, Microbiology.

Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections.

D. Stevens, A. Morgan, Christine Cofer, 2009, Future microbiology.

The effects of iclaprim on exotoxin production in methicillin‐resistant and vancomycin‐intermediate Staphylococcus aureus

D. Stevens, A. Bryant, David B. Huang, 2019, Journal of Medical Microbiology.

Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics.

D. Stevens, A. Bryant, S. Hamilton, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Do cardiomyocytes mount an immune response to Group A Streptococcus?

D. Stevens, A. Bryant, S. Hamilton, 2011, Cytokine.

Structural Biology of Bacterial Pathogenesis

D. Stevens, Dennis Stevens, 2006, Emerging Infectious Diseases.

Effects of environmental factors on streptococcal erythrogenic toxin A (SPE A) production by Streptococcus pyogenes.

D L Stevens, D. Stevens, M. Chaussee, 1997, Advances in experimental medicine and biology.

Streptolysin O modulates cytokine synthesis in human peripheral blood mononuclear cells.

D. Stevens, A. Bryant, 1997, Advances in experimental medicine and biology.

Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureusIn Vitro

D. Stevens, A. Bryant, Sarah E. Hobdey, 2017, Antimicrobial Agents and Chemotherapy.

Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria.

D. Stevens, 2009, The Journal of infection.

D. Stevens, Ferretti Jj, Fischetti Va, 2016 .

Novel therapies in streptococcal toxic shock syndrome: attenuation of virulence factor expression and modulation of the host response.

A. Norrby-Teglund, D. Stevens, 1998, Current opinion in infectious diseases.

Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity

D. Stevens, A. Bryant, 2023, Current opinion in infectious diseases.

Community-acquired Staphylococcus aureus infections: Increasing virulence and emerging methicillin resistance in the new millennium.

D. Stevens, Dennis L Stevens, 2003, Current Opinion in Infectious Diseases.

Cardiac dysfunction in StrepTSS: group A streptococcus disrupts the directional cardiomyocyte-to-macrophage crosstalk that maintains macrophage quiescence.

D. Stevens, A. Bryant, Zhi Li, 2012, Cytokine.

The in vitro antibacterial activity of ceftriaxone against Streptococcus pyogenes is unrelated to penicillin-binding protein 4.

D. Stevens, P. Mendelman, S. Yan, 1993, FEMS microbiology letters.

Gram-positive shock

D. Stevens, A. Bryant, S. Hackett, 1992 .

A critical role of tumor necrosis factor (TNF) alpha in experimental group A streptococcal (GAS) bacteremia.

D. Stevens, A. Bryant, 1997, Advances in experimental medicine and biology.

Characterization of Paeniclostridium sordellii Metalloproteinase-1 in vitro and in an experimental model of infection.

D. Stevens, Sarah E. Hobdey, Al R. Wolfe, 2021, Anaerobe.

Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model.

D. Stevens, A. Bryant, B. Fries, 2010, The Journal of infectious diseases.

Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis.

M. Awad, J. Rood, D. Stevens, 1997, The Journal of infectious diseases.

Group B streptococcal osteomyelitis in adults.

D. Stevens, D. Haburchak, E. Everett, 1978, Southern medical journal (Birmingham, Ala. Print).

Streptococcal toxic shock syndrome.

D. Stevens, 2002, Clinical Microbiology and Infection.

Group B streptococcal infection in 1987.

D. Stevens, 1987, New York state journal of medicine.

Editorial Response: Rationale for the Use of Intravenous Gamma Globulin in the Treatment of Streptococcal Toxic Shock Syndrome

D. Stevens, 1998 .

Editorial

D. Stevens, A. Bryant, 2019, Current Opinion in Infectious Diseases.

Current Opinion in Infectious Diseases

D. Stevens, P. Heath, 2009 .

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

E. P. Dellinger, A. Bisno, J. Montoya, 2014 .

Reply to González del Castillo et al and Rashid and Kravitz.

D. Stevens, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune modulatory effects of antibiotics

D. Stevens, 1996 .

Severe sepsis and septic shock: review of the literature and emergency department management guidelines.

David T. Huang, S. Trzeciak, T. Osborn, 2006, Annals of emergency medicine.

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

A. Bisno, J. Montoya, D. Stevens, 2022 .

Sequential computerized axial tomography in tuberculous meningitis.

D. Stevens, E. Everett, 1978, JAMA.

Role of theta toxin, a sulfhydryl-activated cytolysin, in the pathogenesis of clostridial gas gangrene.

D. Stevens, A. Bryant, 1993, Clinical Infectious Diseases.

Chlorthalidone-associated neutropenia.

D. Stevens, G. Starkebaum, D. L. Stevens, 1982, The Western journal of medicine.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

A. Bisno, J. Montoya, D. Stevens, 2014, Clinical Infectious Diseases.

Effects of delayed NSAID administration after experimental eccentric contraction injury – A cellular and proteomics study

B. Webb-Robertson, T. Clauss, T. Metz, 2017, PloS one.

Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome

P. Schlievert, D. Stevens, Alan R. Hauser, 1991, Journal of clinical microbiology.